by mfenimore | Nov 28, 2023 | Uncategorized
Often seen in Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN), arise as a consequence of immune system involvement and can have myriad health consequences. Both CIDP and MMN are...
by Stefan Ravello | Nov 28, 2023 | Uncategorized
Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments...
by Stefan Ravello | Jul 18, 2023 | Uncategorized
Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on...
by Stefan Ravello | Jul 18, 2023 | Uncategorized
Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (≥ 65 years) throughout the world. In the United States (U.S.), more than 6 million individuals carry this diagnosis, with many yet to be diagnosed. AD follows a...
by Stefan Ravello | May 25, 2023 | Uncategorized
Approximately 70% of all adults in the United States are overweight or have obesity. Unfortunately, obesity remains underdiagnosed and inadequately addressed in routine practice. While enormous strides have been made in recent years relative to the safety and efficacy...
